Alameddine Mahmoud, Jue Joshua S, Morsi Mahmoud, Gonzalez Javier, Defreitas Marissa, Chandar Jayanthi J, Gaynor Jeffrey J, Ciancio Gaetano
Department of Surgery and Urology, Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, 1801 N.W. 9th Ave, Suite 700, FL, 33136, Miami, USA.
Department of Urology, Lenox Hill Hospital, Northwell Health, New York, NY, USA.
BMC Pediatr. 2020 Nov 16;20(1):526. doi: 10.1186/s12887-020-02422-0.
We describe the safety and efficacy of performing pediatric kidney transplantation with a modified extraperitoneal approach that includes mobilization of the native liver and kidney.
We retrospectively identified pediatric renal transplants performed using this technique between 2015 and 2019. Data on patient demographics, surgical technique, and intraoperative details were collected. Outcomes were measured by morbidity and re-operation at 90 days, as well as serum creatinine, allograft survival, and overall survival at 1 year.
Twenty-one patients with a median age of 5 (IQR 3-9) years, weighing 17.5 (IQR 14.5-24) kg were included. Median donor age was 24 (IQR 19-31) years. No intraoperative complications occurred. One child required a right native nephrectomy to allow sufficient space. Postoperatively, all patients had immediate graft function without urine leak or allograft thrombosis. 90-day morbidity and re-operation rates were zero. Both 1-year allograft and overall survival were 100% (on follow-up of all 21 patients through 1 year post-transplant), with a median serum creatinine of 0.58 (IQR 0.47-0.70) mg/dl at 1 year post-transplant.
Pediatric kidney transplantation of adult renal allografts using an extraperitoneal approach with native liver and kidney mobilization has promising allograft and patient survival outcomes that eliminates peritoneal violation and may diminish the need for native nephrectomy.
我们描述了采用改良腹膜外入路进行小儿肾移植的安全性和有效性,该入路包括游离自体肝脏和肾脏。
我们回顾性分析了2015年至2019年间采用该技术进行的小儿肾移植病例。收集了患者人口统计学、手术技术和术中细节等数据。通过90天的发病率和再次手术情况,以及术后1年的血清肌酐水平、移植肾存活率和总生存率来评估治疗效果。
纳入21例患者,中位年龄5(四分位间距3 - 9)岁,体重17.5(四分位间距14.5 - 24)kg。供体中位年龄24(四分位间距19 - 31)岁。术中无并发症发生。1例患儿需要行右侧自体肾切除术以获得足够空间。术后,所有患者移植肾立即恢复功能,无尿漏或移植肾血栓形成。90天发病率和再次手术率均为零。移植肾1年存活率和总生存率均为100%(21例患者均随访至移植后1年),移植后1年血清肌酐中位值为0.58(四分位间距0.47 - 0.70)mg/dl。
采用腹膜外入路并游离自体肝脏和肾脏进行成人肾移植的小儿肾移植,具有良好的移植肾和患者生存结局,避免了腹膜损伤,可能减少自体肾切除的必要性。